Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma

Therapeutic Drug Monitoring

Volumn 27, Issue 3, 2005, Pages 265-269

  Tribut, Olivier ^a   Verdier, Marie Clémence ^a   Arvieux, Cédric ^a   Allain, Hervé ^a   Michelet, Christian ^a   Bentué Ferrer, Danièle ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Atazanavir; HIV; Liquid chromatography; Method; Protease inhibitors

Indexed keywords

ACETONITRILE; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DRUG METABOLITE; EFAVIRENZ; ETHER; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; PYRROLIDINE DERIVATIVE; RITONAVIR; SAQUINAVIR;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV PROTEASE INHIBITORS; HUMANS; OLIGOPEPTIDES; PYRIDINES;

EID: 20044379037     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000162230.83188.32     Document Type: Article

References (24)

1. Goldsmith DR, Perry CM. Atazanavir. Drugs. 2003;63:1679-1693.
2. Van Heeswijk RP, Hoetelmans RM, Harms R, et al. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl. 1998;719:159-168.
3. Poirier JM, Radembino N, Robidou P, et al. Simultaneous determination of the five HIV protease inhibitors: amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction and column liquid chromatography. Ther Drug Monit. 2000;22:465-473.
4. Marzolini C, Telenti A, Buclin T, et al. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Biomed Sci Appl. 2000;740:43-58.
5. Proust V, Toth K, Hulin A, et al. Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma. J Chromatogr B Biomed Sci Appl. 2000;742:453-458.
6. Aymard G, Legrand M, Trichereau N, et al. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl B. 2000;744:227-240.
7. Yamada H, Kotaki H, Nakamura T, et al. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl B. 2001;755:85-89.
8. Sarasa-Nacenta M, Lopez-Pua Y, Mallolas J, et al. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl B. 2001;757:325-332.
9. Dailly E, Thomas L, Kergueris MF, et al. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir, saquinavir) after liquid-liquid extraction. J Chromatogr B Biomed Sci Appl B. 2001;758:129-135.
10. Kuschak D, Mauss S, Schmutz G, et al. Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC. Clin Lab. 2001;47:471-477.
11. Titier K, Lagrange F, Pehourcq F, et al. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma. Ther Drug Monit. 2002;24:417-424.
12. Keil K, Frerichs VA, DiFrancesco R, et al. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma. Ther Drug Monit. 2003;25:340-346.
13. Droste JA, Verweij-Van Wissen CP, Burger DM. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography. Ther Drug Monit. 2003;25:393-399.
14. Cociglio M, Hilaire-Buys D, Peyriere H, et al. Performance analysis of a rapid HPLC determination with the solvent demixing extraction of HIV antiproteases and efavirenz in plasma. J Chromatogr Sci. 2003;41:80-86.
15. Justensen US, Pedersen C, Klitgaard NA. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography. J Chromatogr B Biomed Sci Appl. 2003;783:491-500.
16. Turner ML, Reed-Walker K, King JR, et al. Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography. J Chromatogr B Biomed Sci Appl. 2003;784:331-341.
17. Rezk NL, Tidwell RR, Kashuba AD. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma. J Chromatogr B Biomed Sci Appl. 2004;805:241-247.
18. Schuster A, Burzawa S, Jemal M, et al. Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction. J Chromatogr B Biomed Sci Appl. 2003;788:377-386.
19. Jemal M, Rao S, Gatz M, et al. Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for high-throughput analysis. J Chromatogr B Biomed Sci Appl. 2003;795:273-289.
20. Crommentuyn KM, Rosing H, Hillebrand MJ, et al. Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Chromatogr B Biomed Sci Appl B. 2004;804:359-367.
21. Tribut O, Arvieux C, Michelet C, et al. Simultaneous quantificative assay of six HIV protease inhibitors, one metabolite and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography. Ther Drug Monit. 2002;24:554-562.
22. Daily E, Raffi F, Jolliet P. Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection. J Chromatogr B Biomed Sci Appl. 2004;813:353-358.
23. th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 10-14, 2002, p 537.
24. Delfraissy JF. Prise en charge thérapeutique des personnes infectées par le VIH. Recommandations du groupe d'experts. Paris: Médecine-Sciences, Flammarion, 2004, p 127.